Hemispherx BioPharma Inc.

(HEB)

By |

Profile

Hemispherx Biopharma Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The business segment of the firm is to perform research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The sales revenue of the company is derived from the United States.

Contact Information

Website: www.hemispherx.net
Email: info@hemispherx.net
Main Phone: +1 215 988-0080
Address: 860 North Orange Avenue
Address 2: Suite B
State: FL
City / Town: Orlando
Country: USA
Postal Code: 32801

Issuer Information

Exchange: AMX
CEO: Thomas K. Equels
Employees: 27
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.19 $ -0.0065 (-3.32%)
Last Price 0.19 Change $ -0.0065 Change % -3.32 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.19 High 0.20 Low 0.19 Prev Close 0.20
Last Trade Volume 101,782 52 Wk Hi 0.65 52 Wk Low 0.15
Market Cap 9.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 48,189,570.00 EPS (TTM) -0.25 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 18 54
Number of Buys 18 54
Number of Sells 0 0
Net Activity 2115274 3796128
Last 10 Buys Shares
Stewart L. Appelrouth 1,000
Thomas K. Equels 1,000
David R. Strayer 1,000
Adam Pascale 1,000
Wayne S. Springate 1,000
Peter W. Rodino 1,000
Thomas K. Equels 1,000
Thomas K. Equels 1,000
Adam Pascale 1,000
David R. Strayer 1,000
Last 10 Sell Shares
William A. Carter 1,000
William A. Carter 1,000
William A. Carter 1,000
William A. Carter 1,000
David R. Strayer 1,000
David R. Strayer 1,000
David R. Strayer 1,000
Charles T. Bernhardt 1,000
Wayne S. Springate 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 01/21/14 01/21/14 01/21/14 01/21/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1